The U.S. Food and Drug Administration (FDA) approved GSK's combination vaccine to protect against meningococcal infection for ...
Hedge fund Citadel has made a 305 million pound ($384.5 million) bet against drugmaker GSK , the Financial Times reported on ...
Two Trump administration nominees with long track records of challenging the medical and public health establishments have ...
The health of our society is fundamental to our economy, and investing in healthcare and systems is essential for our future ...
In line with recent developments in the GST registration process, applicants must adhere to the following steps as per Rule 8 ...
GSK PLC closed 20.84% below its 52-week high of £18.24, which the company achieved on May 16th.
Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to allow it to ...
Subsidies and existing MediSave schemes could possibly bring the out-of-pocket cost of Shingrix down to zero, says Health ...
When drug companies manipulate the system to increase profits, patients suffer. Arizona Attorney General Kris Mayes is right to take GlaxoSmithKline to court over its decision to discontinue Flovent, ...
The state’s top lawyer accused a British multinational drug company of “deceptive and unfair practices” that endangered lives and exploited American taxpayers.
January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results